A. Mogenet

717 total citations
6 papers, 504 citations indexed

About

A. Mogenet is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, A. Mogenet has authored 6 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in A. Mogenet's work include Diabetes and associated disorders (1 paper), Mitochondrial Function and Pathology (1 paper) and Electrolyte and hormonal disorders (1 paper). A. Mogenet is often cited by papers focused on Diabetes and associated disorders (1 paper), Mitochondrial Function and Pathology (1 paper) and Electrolyte and hormonal disorders (1 paper). A. Mogenet collaborates with scholars based in France, United States and Belgium. A. Mogenet's co-authors include Pierre Quartier, Olivier Richer, Paul Landais, A. Duquesne, Damien Chaussabel, Rolando Cimaz, Xavier Bossuyt, Jean‐Marc Tréluyer, Jacques Bienvenu and Florence Allantaz and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinical Pharmacology & Therapeutics and Pediatric Nephrology.

In The Last Decade

A. Mogenet

6 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Mogenet France 5 302 218 144 138 107 6 504
Sarah L. N. Clarke United Kingdom 10 188 0.6× 315 1.4× 38 0.3× 101 0.7× 52 0.5× 23 649
Marek Böhm Czechia 7 108 0.4× 162 0.7× 18 0.1× 46 0.3× 47 0.4× 9 343
Violetta Opoka‐Winiarska Poland 12 105 0.3× 52 0.2× 46 0.3× 34 0.2× 65 0.6× 31 328
Zaynab Alourfi Syria 11 47 0.2× 47 0.2× 17 0.1× 315 2.3× 42 0.4× 24 520
Astrid Thilén Sweden 12 161 0.5× 751 3.4× 17 0.1× 19 0.1× 37 0.3× 17 926
Florence Uettwiller France 9 123 0.4× 55 0.3× 33 0.2× 54 0.4× 45 0.4× 17 268
Sandrine Meunier France 12 346 1.1× 171 0.8× 10 0.1× 12 0.1× 51 0.5× 45 578
Ane Miren Andrés Spain 13 54 0.2× 31 0.1× 19 0.1× 25 0.2× 245 2.3× 42 424
Rita Balter Italy 12 92 0.3× 29 0.1× 5 0.0× 46 0.3× 66 0.6× 36 361
Rita Jerath United States 8 50 0.2× 30 0.1× 15 0.1× 62 0.4× 31 0.3× 17 337

Countries citing papers authored by A. Mogenet

Since Specialization
Citations

This map shows the geographic impact of A. Mogenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mogenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mogenet more than expected).

Fields of papers citing papers by A. Mogenet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Mogenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mogenet. The network helps show where A. Mogenet may publish in the future.

Co-authorship network of co-authors of A. Mogenet

This figure shows the co-authorship network connecting the top 25 collaborators of A. Mogenet. A scholar is included among the top collaborators of A. Mogenet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Mogenet. A. Mogenet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Quartier, Pierre, Florence Allantaz, Rolando Cimaz, et al.. (2010). A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Annals of the Rheumatic Diseases. 70(5). 747–754. 381 indexed citations
2.
Bonnefont, Jean‐Paul, Jean Bastin, Pascal Laforêt, et al.. (2010). Long-Term Follow-Up of Bezafibrate Treatment in Patients With the Myopathic Form of Carnitine Palmitoyltransferase 2 Deficiency. Clinical Pharmacology & Therapeutics. 88(1). 101–108. 87 indexed citations
3.
Sermet‐Gaudelus, Isabelle, Teresinha Leal, K. De Boeck, et al.. (2008). PTC124 induces CFTR full-length production and activity in children with nonsense-mutation-mediated CF. Journal of Cystic Fibrosis. 7. S22–S22. 8 indexed citations
4.
Bachelot, Anne, Kathleen Laborde, Geneviève Plu‐Bureau, et al.. (2007). Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism. Journal of Endocrinological Investigation. 30(8). 636–646. 11 indexed citations
5.
Guest, G., Christine Le Bihan-Benjamin, Anne Maisin, et al.. (2004). Glucocorticoid pharmacokinetics and growth retardation in children with renal transplants. Pediatric Nephrology. 19(8). 898–904. 16 indexed citations
6.
Boîtard, Christian, et al.. (1991). [Decrease of early insulin secretion, risk factor of insulin-dependent diabetes. Prospective study in families with diabetic children].. PubMed. 48(1). 11–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026